Wednesday, 20 April 2022

Biotech Breakthrough “Like Science Fiction,=?UTF-8?B?4oCd?=Remarks Doctor

Dear Reader,

Its codename is “CTX.”

And a Nobel Prize winner has gone on record stating
this tech could soon mean the end of human disease as we know it.

Its recent shocking trial results have been hailed as a “Landmark.” As one researcher and surgeon puts it, this tech feels “like science fiction.”

It's set to generate trillions of dollars in the months and years ahead.

It's backed by a laundry list of billionaires including Elon Musk, Jeff Bezos, Bill Gates, and Sean Parker. Google, Stanford, and the FDA have all lined up behind it too.

Yet somehow, this tech doesn't belong to Big Pharma or Big Tech…

It belongs to a small group of biotech firms you've probably never heard of.

No matter what's happening in the world around us these days…

If you can invest in this tech now, before it breaks out into the public eye, it could very well be the financial move of a lifetime.

I go over all the details in my recent interview with national television host Chris Hurt.

Click here to watch or read for yourself. I'll see you there.

Regards,

Jeff Brown
Founder, Brownstone Research

20181114

No comments:

Post a Comment

Breaking News Hits Wire: TC BioPharm (NASDAQ: TCBP) Makes Approx 189% Early Move

  *Sponsored After an Approximate 1,041% Move in Under 3 Months From a Recent BioPharma Profile, Ou...